Our in vitro data suggest that Trp metabolite IA can effectively inhibit the release of pro-inflammatory factors IL-6 from astrocytes induced by NMO-IgG, and its anti-inflammatory effect may be mediated by AHR, at least partially. This evidence concerns the gene IL6 and neuromyelitis optica.